Cosmos Health Posts Record Revenue, Retires Debt Early
Event summary
- Cosmos Health reported record revenue for three consecutive quarters, with H1 2026 revenue reaching $36.91M, up 29.7% YoY.
- The company retired an $8M convertible note 12 months early, eliminating dilution risk.
- C-Scrub was placed in Tesco and Superdrug, the UK's top two health/beauty retailers.
- Sky Premium Life secured a 5-year exclusive distribution deal in Saudi Arabia with Innova Healthcare.
- CEO Greg Siokas increased his ownership to 14.6M shares through personal investments.
The big picture
Cosmos Health's transformation reflects a broader trend in the healthcare sector toward vertical integration and international expansion. The company's ability to retire debt early while increasing revenue highlights its operational efficiency and strategic focus on high-margin proprietary products. The placement of C-Scrub in major UK retailers and the exclusive Saudi Arabia deal for Sky Premium Life position Cosmos Health for significant growth in key markets.
What we're watching
- Revenue Growth
- Whether Cosmos Health can sustain its 29.7% YoY revenue growth through the second half of 2026 and meet its $90M+ full-year guidance.
- Debt Management
- The impact of the $8M debt retirement on the company's financial flexibility and ability to fund future growth initiatives.
- International Expansion
- The pace at which Cosmos Health can scale its international distribution agreements, particularly in the Middle East and Europe.
Related topics